Zhitong Finance App News, China Biopharmaceuticals (01177.HK) announced that the Group has signed a strategic option and licensing agreement (agreement) with Boehringer Ingelheim. This is the second cooperation between the two sides in the field of oncology. The two sides are committed to jointly establishing a long-term strategic partnership.
智通财经·11/04/2026 08:42:10
语音播报
Zhitong Finance App News, China Biopharmaceuticals (01177.HK) announced that the Group has signed a strategic option and licensing agreement (agreement) with Boehringer Ingelheim. This is the second cooperation between the two sides in the field of oncology. The two sides are committed to jointly establishing a long-term strategic partnership.